Dr. Giuseppe Tarantini (Professor and Director of Interventional Cardiology, University of Padua, Italy) speaks on the importance of the early unloading concept in cardiogenic shock (CS), in bringing about improvements in systemic circulation ahead of coronary reperfusion, with the hope that this could improving mortality rates in such patients. The choice of left ventricular mechanical … Continue reading “Impella in Cardiogenic Shock: The Importance of Early Unloading”
Dr. Alexander Truesdell, Interventional Cardiologist at Inova Heart and Vascular Institute discusses his editorial, the War on Shock, published in the Journal of Invasive Cardiology. The editorial compares his experience as a military physician with his experience as a cardiologist treating cardiogenic shock. Watch the video to learn which systems of care Dr. Truesdell suggests … Continue reading “Identifying Cardiogenic Shock Early with a Heart Team Approach”
- This retrospective study evaluated observational data of patients receiving either early or delayed initiation of Impella for the management of acute myocardial infarction complicated by cardiogenic shock (AMICS).
- Receiving mechanical circulatory support (MCS) prior to percutaneous coronary intervention (PCI) compared with post-PCI initiation was associated with a higher survival rate to discharge among AMICS patients.
- Overall survival to discharge for the cohort was 44%.
- Additionally, early initiation of MCS at the first signs of shock and before inotropes, vasopressors, and PCI correlated with a higher rate of survival.
- This meta-analysis evaluated 6 randomized controlled trials to determine outcome differences between percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG) among patients with unprotected left main coronary artery disease ([ULMCAD] n = 4686).
- Compared with CABG, PCI correlated with significantly lower rates of 30-day stroke (P = 0.007), death or MI (P = 0.04), or all-cause death, MI, or stroke (P = 0.01).
- In the PCI group, there was a significantly lower rate of 30-day stroke incidence (P = 0.007) and all-cause death, MI, or stroke (P = 0.01).
- The authors found no significant difference in outcomes at long-term follow-up (median 39 months) between the two groups.
Case Review: High-Risk PCI Case Using Impella® Heart Pump Support on an Unprotected Left Main Coronary Artery
Dr. David Lasorda presents a high-risk PCI case using Impella® heart pump support to address an unprotected left main coronary artery with orbital atherectomy. Subscribe, tweet this or join the conversation by following us on Twitter: @ProtectedPCI. IM2-051-17 To learn more about the Impella® platform of heart pumps, including important risk and safety information associated with the use … Continue reading “Case Review: High-Risk PCI Case Using Impella® Heart Pump Support on an Unprotected Left Main Coronary Artery”
Dr. Benham Tehrani of Inova Heart and Vascular Institute explains an After Action Review (AAR) program to evaluate the shock program at his hospital. Watch the video to learn how to initiate an AAR program. Subscribe, tweet this or join the conversation by following us on Twitter: @ProtectedPCI. NPS-097-17
Dr. Raja Hatem has created more than 100 PowerPoint presentations. He explains how to make an impactful PowerPoint for presenting case reviews. IM2-052-17 To learn more about the Impella® platform of heart pumps, including important risk and safety information associated with the use of the devices, please visit: www.protectedpci.com/indications-use-safety-information/
Abiomed’s Sheila Gebel and Maggie Flynn explain the role and importance of a Protected PCI Coordinator and the use of algorithms and protocols. NPS-050-17
Michael Hacala, Detroit Cardiogenic Shock (DCSI) Coordinator at Henry Ford Hospital. Tune in to hear updates about the program, and learn how to participate. Partnering hospital systems participating in DCSI use a defined protocol for early placement of Impella in patients in cardiogenic shock. Since July, initial results from a small sampling of 30 patients … Continue reading “Specialist Opinion: Updates on Detroit Cardiogenic Shock Initiative with Michael Hacala”
Dr. Perwaiz Meraj of Northwell Health discusses a new study demonstrating potential survival with Impella 2.5® heart pump insertion pre-PCI in heart attacks involving the left main coronary artery. IM2-049-17